Sicara-Robineau syndrome is a rare hereditary disease that is characterized by neurodevelopmental disorders and various physical defects. It is named after the French scientists R. Sicard and Robert Robineau, who described the syndrome in 1956.
The syndrome manifests itself in the form of various developmental anomalies, such as underdevelopment of the brain, impaired vision, hearing and coordination of movements. Various physical defects may also be observed, such as heart defects, skull defects, developmental delays and others.
Treatment for Sicard-Robineau syndrome involves the use of various treatment methods, such as surgery, medication, and rehabilitation. However, since the syndrome is rare and poorly understood, treatment can be difficult and not always effective.
It is important to note that Sicara-Robeno syndrome occurs in only a few hundred people worldwide, and most of them live in isolated communities. Therefore, despite the fact that this syndrome is a serious disease, it is not common and its treatment is possible only with the help of qualified specialists.